Cargando…
Response to “Evaluating Adverse Events in Databases”
Autores principales: | Calapai, Fabrizio, Mannucci, Carmen, Cardia, Luigi, Currò, Mariaconcetta, Calapai, Gioacchino, Esposito, Emanuela, Ammendolia, Ilaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433452/ https://www.ncbi.nlm.nih.gov/pubmed/37589310 http://dx.doi.org/10.1002/prp2.1127 |
Ejemplares similares
-
Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
por: Calapai, Fabrizio, et al.
Publicado: (2023) -
Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution
por: Calapai, Fabrizio, et al.
Publicado: (2023) -
Pharmacovigilance on cannabidiol as an antiepileptic agent
por: Ammendolia, Ilaria, et al.
Publicado: (2023) -
Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives
por: Calapai, Fabrizio, et al.
Publicado: (2022) -
Effects of Cannabidiol on Locomotor Activity
por: Calapai, Fabrizio, et al.
Publicado: (2022)